Recurrence of atrial fibrillation after internal cardioversion of persistent atrial fibrillation: Prognostic importance of electrophysiologic parameters

Circulation Journal

Volumn 69, Issue 12, 2005, Pages 1514-1520

  Okumura, Yasuo ^a   Watanabe, Ichiro ^a   Nakai, Toshiko ^a   Sugimura, Hidezou ^a   Hashimoto, Kenichi ^a   Masaki, Riko ^a   Ohkubo, Kimie ^a   Takagi, Yasuhiro ^a   Shindo, Atsushi ^a   Ozawa, Yukio ^a   Saito, Satoshi ^a   Kanmatsuse, Katsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Electrical remodeling; Filtered P wave duration; Internal cardioversion; Monophasic action potential

Indexed keywords

ADULT; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; ECG ABNORMALITY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART RIGHT ATRIUM; HEART SIZE; HUMAN; MALE; MULTIVARIATE ANALYSIS; P WAVE; PREDICTION; RECURRENT DISEASE; SAMPLE SIZE; SIGNAL AVERAGED ELECTROCARDIOGRAPHY;

ACTION POTENTIALS; AGED; ATRIAL FIBRILLATION; BEPRIDIL; CARBAZOLES; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPANOLAMINES; RECURRENCE; RISK FACTORS;

EID: 28544443595     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.69.1514     Document Type: Article

References (49)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982; 306: 1018 - 1022.
2. Kalman JM, Tonkin AM. Atrial fibrillation: Epidemiology and the risk and prevention of stroke. Pacing Clin Electrophysiol 1992; 15: 1332 - 1346.
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946 - 952.
4. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomized trial. Lancet 2000; 356: 1789 - 1794.
5. Atrial Fibrillation Follow-up Investigators of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2000; 347: 1825 - 1833.
6. Sopher SM, Murgatroyd FD, Slade AK, Blankoff I, Rowland E, Ward DE, et al. Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks. Heart 1996; 75: 635 - 638.
7. Levy S, Ricard P, Lau CP, Lok NS, Camm AJ, Murgatroyd FD, et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997; 29: 750 - 755.
8. Juul-Moller S, Edvardsson N, Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990; 82: 1932 - 1939.
9. Van Gelder IC, Crijns HJ, Van Gilst WH, Van Wijk LM, Hamer HP, Lie KI. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol 1989; 64: 1317 - 1321.
10. Van Gelder IC, Crijns HJ. Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm. Pacing Clin Electrophysiol 1997; 20: 2675 - 2683.
11. Wijffels MC, Kirchhoff CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995; 92: 1954 - 1968.
12. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995; 91: 1588 - 1595.
13. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation: Time course and mechanisms. Circulation 1996; 94: 2968 - 2974.
14. Opolski G, Scislo P, Stanislawska J, Gorecki A, Steckiewicz R, Torbicki A. Detection of patients at risk for recurrence of atrial fibrillation after successful electrical cardioversion by signal-averaged P-wave ECG. Int J Cardiol 1997; 60: 181 - 185.
15. Aytemir K, Aksoyek S, Yildirir A, Ozer N, Oto A. Prediction of atrial fibrillation recurrence after cardioversion by P wave signal-averaged electrocardiography. Int J Cardiol 1999; 70: 15 - 21.
16. Raitt MH, Ingram KD, Thurman SM. Signal-averaged P wave duration predicts early recurrence of atrial fibrillation after cardioversion. Pacing Clin Electrophysiol 2000; 23: 259 - 265.
17. Franz MR, Swerdlow CD, Liem LB, Schaefer J. Cycle length dependence of human action potential duration in vivo: Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest 1988; 82: 972 - 979.
18. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976; 53: 273 - 279.
19. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991; 68: 41 - 46.
20. Alt E, Ammer R, Lehmann G, Putter K, Ayers GM, Pasquantonio J, et al. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with sotalol. Am Heart J 1997; 134: 419 - 425.
21. Brodsky MA, Allen BJ, Capparelli EV, Luckett CR, Morton R, Henry WL. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol 1989; 63: 1065 - 1068.
22. Van Gelder IC, Crijns HJ, Tieleman RG, Brugemann J, De Kam PJ, Gosselink AT, et al. Chronic atrial fibrillation: Success of serial car-dioversion therapy and safety of oral anticoagulation. Arch Intern Med 1996; 156: 2585 - 2592.
23. Franz MR, Karasik PL, Li C, Moubarak J, Chavez M. Electrical remodeling of the human atrium: Similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1997; 30: 1785 - 1792.
24. Osaka T, Itoh A, Kodama I. Action potential remodeling in the human right atrium with chronic lone atrial fibrillation. Pacing Clin Electrophysiol 2000; 23: 960 - 965.
25. Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A. Atrial fibrillation recurrence after internal cardioversion: Prognostic importance of electrophysiological parameters. Heart 2002; 87: 443 - 448.
26. Manios EG, Kanoupakis EM, Chlouverakis GI, Kaleboubas MD, Mavrakis HE, Vardas PE. Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: Relation with recurrence. Cardiovasc Res 2000; 47: 244 - 253.
27. Daoud EG, Bogun F, Goyal R, Harvey M, Man C, Strickberger A, et al. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996; 94: 1600 - 1606.
28. Olsson SB, Cotoi S, Varnauskas E. Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation. Acta Med Scand 1971; 190: 381 - 387.
29. Polgar P, Worum F, Kovacs P, Lorincz I, Kakuk GY. The prognostic value of right atrial monophasic action potential after conversion of atrial fibrillation. Prog Biomed Res 1999; 4: 207 - 209.
30. Pandozi C, Bianconi L, Villani M, Gentilucci G, Castro A, Altamura G, et al. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. Circulation 1998; 98: 2860 - 2865.
31. Shinagawa K, Li D, Leung TK, Nattel S. Consequences of atrial tachycardia-induced remodeling depend on the preexisting atrial substrate. Circulation 2002; 105: 251 - 257.
32. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997; 96: 3157 - 3163.
33. van der Velden HM, Ausma J, Rook MB, Hellemons AJ, van Veen TA, Allessie MA, et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 2000; 46: 476 - 486.
34. Everett TH 4th, Li H, Mangrum M, McRury ID, Mitchell MA, Redick JA, et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000; 102: 1454 - 1460.
35. Nishino M, Hoshida S, Tanouchi J, Ito T, Kato J, Iwai K, et al. Time to recover from atrial hormonal, mechanical, and electrical dysfunction after successful electrical cardioversion of persistent atrial fibrillation. Am J Cardiol 2000; 85: 1451 - 1454.
36. Stafford PJ, Kamalvand K, Tan K, Vincent R, Sulke N. Prediction of maintenance of sinus rhythm after cardioversion of atrial fibrillation by analysis of serial signal-averaged P waves. Pacing Clin Electrophysiol 1998; 21: 1387 - 1395.
37. Yu W, Lee SH, Tai CT, Tsai CF, Hsieh MH, Chen CC, et al. Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 1999; 42: 470 - 476.
38. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation: Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000; 342: 913 - 920.
39. Fujiki A, Tsuneda T, Sakabe M, Nakagawa K, Mizumaki K, Hirai T, et al. Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation. Circ J 2004; 68: 834 - 839.
40. Nakazato Y, Yasuda M, Sasaki A, Iida Y, Kawano Y, Nakazato K, et al. Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation. Circ J 2005; 69: 44 - 48.
41. Anno T, Furuta T, Itho M, Kodama I, Toyama J, Yamada K. Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles. Br J Pharmacol 1984; 81: 589 - 597.
42. Nobe S, Aomine M, Arita M. Bepridil prolongs the action potential duration of guinea pig ventricular muscle only at rapid rates of stimulation. Gen Pharmacol 1993; 24: 1187 - 1196.
43. Yue L, Feng J, Gaspo R, LiGR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 1997; 81: 512 - 525.
44. Yamashita T, Nakajima T, Hazama H, Hamada E, Murakawa Y, Sawada K, et al. Regional differences in transient outward current density and inhomogeneities of repolarization in rabbit right atrium. Circulation 1995; 92: 3061 - 3069.
45. Feng J, Yue L, Wang Z, Nattel S. Ionic mechanisms of regional action potential heterogeneity in the canine right atrium. Circ Res 1998; 83: 541 - 551.
46. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation 1998; 98: 2202 - 2209.
47. Lee SH, Lin FY, Yu WC, Cheng JJ, Kuan P, Hung CR, et al. Regional differences in the recovery course of tachycardia-induced changes of atrial electrophysiological properties. Circulation 1999; 99: 1255 - 1264.
48. Pederson OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999; 100: 376 - 380.
49. Van Den Berg MP, Crijns HJ, Van Veldhuisen DJ, Griep N, De Kam PJ, Lie KI. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail 1995; 1: 355 - 364.